The Senate Health, Education, Labor and Pensions Committee has formed a new investigations unit to "play an active role in consumer protection and to make sure that public money is spent well rather than wasted or squandered through fraud," committee Chairman Tom Harkin, D-Iowa, announced May 5

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials